While the primary focus will be on individuals with these specific proteasome-related disorders, the remarkable similarities observed between the cellular characteristics of individuals with PSMC5 variants and those with neurodegenerative diseases suggest that these therapeutic strategies could eventually benefit a broader population. Here, PSMC5 is linked to neurodegenerative disease.